CARLSBAD, CALIFORNIA--(Marketwired - March 28, 2014) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it will be participating at the 82nd Annual Meeting of the American Association of Neurological Surgeons (AANS) taking place April 5-9, 2014, at The Moscone Center in San Francisco.
The theme for the 2014 AANS Meeting is Expanding Neurosurgery. At the meeting, Aurora Spine will continue to extend the reach of the ZIP ULTRA™ MIS Interspinous Fusion system, exhibit its MIS portfolio, and drive the shift toward minimally invasive techniques.
"The American Association of Neurological Surgeons is a meeting we as a company always look forward to attending and we are proud to support such an important meeting" said Brent Johnston, Chief Commercial Officer of Aurora Spine. "If you are attending, please stop by Aurora Spine booth #1825 for demonstrations and product information."
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning Aurora Spine's products. Aurora Spine cautions investors of its securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.